0000950170-23-033494.txt : 20230719 0000950170-23-033494.hdr.sgml : 20230719 20230719151458 ACCESSION NUMBER: 0000950170-23-033494 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230717 FILED AS OF DATE: 20230719 DATE AS OF CHANGE: 20230719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BB BIOTECH AG CENTRAL INDEX KEY: 0000924223 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32979 FILM NUMBER: 231096549 BUSINESS ADDRESS: STREET 1: SCHWERTSTRASSE 6 CITY: SCHAFFHAUSEN STATE: V8 ZIP: 8200 BUSINESS PHONE: 411724 59 59 MAIL ADDRESS: STREET 1: SCHWERTSTRASSE 6 CITY: SCHAFFHAUSEN STATE: V8 ZIP: 8200 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIOTECH TARGET N V CENTRAL INDEX KEY: 0001259870 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32979 FILM NUMBER: 231096550 MAIL ADDRESS: STREET 1: ARA HILL TOP BUILDING, UNIT A-5 STREET 2: PLETTERIJWEG OOST 1, CURACAO CITY: WILLEMSTAD STATE: P8 ZIP: 000000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Molecular Templates, Inc. CENTRAL INDEX KEY: 0001183765 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943409596 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 BUSINESS PHONE: 512 896 1555 MAIL ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 FORMER COMPANY: FORMER CONFORMED NAME: THRESHOLD PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020828 4 1 ownership.xml 4 X0508 4 2023-07-17 0001183765 Molecular Templates, Inc. MTEM 0001259870 BIOTECH TARGET N V ARA HILL TOP BUILDING, UNIT A-5 PLETTERIJWEG OOST 1 CURACAO P8 00000 NETHERLANDS ANTILLES false false true false 0000924223 BB BIOTECH AG SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 CH-8200 SWITZERLAND false false true false false Common Stock 2023-07-17 4 P false 4255319 0.470 A 15447322 D Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Molecular Templates, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V. /s/Ivo Betschart 2023-07-19 /s/Martin Gubler 2023-07-19